Daily News Podcast

Galectin-3: A post-MI prognostic biomarker for our times


 

Is galectin-3 a post-MI prognostic biomarker for out times?Also today, postmenopausal estrogen use is down since 2006, watching for substance abuse risks among reservists who have never been deployed, and do free meals for physicians affect opioid prescribing?

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Smoking tied to localized prostate cancer recurrence, metastasis, death
MDedge Dermatology
FDA approves rituximab for treating pemphigus vulgaris
MDedge Dermatology
Suicide rate jumps 30%
MDedge Dermatology
New cell-free DNA assays hold promise for lung cancer screening
MDedge Dermatology
Allergies linked to autism spectrum disorder in children
MDedge Dermatology
Study finds widespread use of medications with depression as side effect
MDedge Dermatology
Type 2 diabetes may promote Parkinson development
MDedge Dermatology
Routine AAA screening for older men: more harm than good?
MDedge Dermatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Dermatology
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Dermatology